Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00309179
Status:
COMPLETED
Last Update Posted:
2017-09-14
First Post:
2006-03-29
Brief Title:
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer Preceded by a Run-in Study in Advanced Solid Tumors
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Organization Data
Organization:
Eisai Inc
Class:
INDUSTRY
Study ID:
E7820-A001-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eisai Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None